Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)

Clinical trial NCT05996835 · COMPLETED

Trial details

NCT number: NCT05996835
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Kidney Injury Due to Sepsis

Start date: 2024-01-18
Primary completion: 2026-02-25
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.